450 related articles for article (PubMed ID: 10904510)
1. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP).
Perry HM; Davis BR; Price TR; Applegate WB; Fields WS; Guralnik JM; Kuller L; Pressel S; Stamler J; Probstfield JL
JAMA; 2000 Jul; 284(4):465-71. PubMed ID: 10904510
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
Davis BR; Vogt T; Frost PH; Burlando A; Cohen J; Wilson A; Brass LM; Frishman W; Price T; Stamler J
Stroke; 1998 Jul; 29(7):1333-40. PubMed ID: 9660383
[TBL] [Abstract][Full Text] [Related]
3. Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP).
Kostis JB; Berge KG; Davis BR; Hawkins CM; Probstfield J
Am J Hypertens; 1995 Dec; 8(12 Pt 1):1147-53. PubMed ID: 8998247
[TBL] [Abstract][Full Text] [Related]
4. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J
JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014
[TBL] [Abstract][Full Text] [Related]
5. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.
JAMA; 1991 Jun; 265(24):3255-64. PubMed ID: 2046107
[TBL] [Abstract][Full Text] [Related]
6. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group.
Kostis JB; Davis BR; Cutler J; Grimm RH; Berge KG; Cohen JD; Lacy CR; Perry HM; Blaufox MD; Wassertheil-Smoller S; Black HR; Schron E; Berkson DM; Curb JD; Smith WM; McDonald R; Applegate WB
JAMA; 1997 Jul; 278(3):212-6. PubMed ID: 9218667
[TBL] [Abstract][Full Text] [Related]
7. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.
Kjeldsen SE; Dahlöf B; Devereux RB; Julius S; Aurup P; Edelman J; Beevers G; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Snapinn S; Wedel H;
JAMA; 2002 Sep; 288(12):1491-8. PubMed ID: 12243636
[TBL] [Abstract][Full Text] [Related]
8. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP).
Franse LV; Pahor M; Di Bari M; Shorr RI; Wan JY; Somes GW; Applegate WB
J Hypertens; 2000 Aug; 18(8):1149-54. PubMed ID: 10954008
[TBL] [Abstract][Full Text] [Related]
9. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group.
Savage PJ; Pressel SL; Curb JD; Schron EB; Applegate WB; Black HR; Cohen J; Davis BR; Frost P; Smith W; Gonzalez N; Guthrie GP; Oberman A; Rutan G; Probstfield JL; Stamler J
Arch Intern Med; 1998 Apr; 158(7):741-51. PubMed ID: 9554680
[TBL] [Abstract][Full Text] [Related]
10. Long-term fatal outcomes in subjects with stroke or transient ischemic attack: fourteen-year follow-up of the systolic hypertension in the elderly program.
Patel AB; Kostis JB; Wilson AC; Shea ML; Pressel SL; Davis BR
Stroke; 2008 Apr; 39(4):1084-9. PubMed ID: 18309155
[TBL] [Abstract][Full Text] [Related]
11. The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group.
Probstfield JL; Applegate WB; Borhani NO; Curb JD; Cutler JA; Davis BR; Furberg CD; Hawkins CM; Lakatos E; Page LB
Clin Exp Hypertens A; 1989; 11(5-6):973-89. PubMed ID: 2676266
[TBL] [Abstract][Full Text] [Related]
12. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
[TBL] [Abstract][Full Text] [Related]
13. Isolated systolic hypertension: lowering the risk of stroke in older patients. SHEP Cooperative Research Group.
Petrovitch H; Vogt TM; Berge KG
Geriatrics; 1992 Mar; 47(3):30-2, 35-8. PubMed ID: 1544585
[TBL] [Abstract][Full Text] [Related]
14. Implications of the systolic hypertension in the elderly program. The Systolic Hypertension in the Elderly Program Cooperative Research Group.
Hypertension; 1993 Mar; 21(3):335-43. PubMed ID: 8478043
[TBL] [Abstract][Full Text] [Related]
15. Association between chlorthalidone treatment of systolic hypertension and long-term survival.
Kostis JB; Cabrera J; Cheng JQ; Cosgrove NM; Deng Y; Pressel SL; Davis BR
JAMA; 2011 Dec; 306(23):2588-93. PubMed ID: 22187278
[TBL] [Abstract][Full Text] [Related]
16. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).
Papademetriou V; Farsang C; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Skoog I; Trenkwalder P; Zanchetti A;
J Am Coll Cardiol; 2004 Sep; 44(6):1175-80. PubMed ID: 15364316
[TBL] [Abstract][Full Text] [Related]
17. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
[TBL] [Abstract][Full Text] [Related]
18. Association of orthostatic hypertension with mortality in the Systolic Hypertension in the Elderly Program.
Kostis WJ; Sargsyan D; Mekkaoui C; Moreyra AE; Cabrera J; Cosgrove NM; Sedjro JE; Kostis JB; Cushman WC; Pantazopoulos JS; Pressel SL; Davis BR
J Hum Hypertens; 2019 Oct; 33(10):735-740. PubMed ID: 30804464
[TBL] [Abstract][Full Text] [Related]
19. The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study.
Kjeldsen SE; Lyle PA; Kizer JR; Dahlöf B; Devereux RB; Julius S; Beevers G; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Snapinn SM; Harris KE; Wedel H;
J Clin Hypertens (Greenwich); 2005 Mar; 7(3):152-8. PubMed ID: 15785156
[TBL] [Abstract][Full Text] [Related]
20. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program.
Applegate WB; Pressel S; Wittes J; Luhr J; Shekelle RB; Camel GH; Greenlick MR; Hadley E; Moye L; Perry HM
Arch Intern Med; 1994 Oct; 154(19):2154-60. PubMed ID: 7944835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
